LOADING
Comparing Pfizer Inc (PFE) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PFE | QCOM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $137.8B | $199.4B |
| P/E Ratio | 18.4 | 20.3 |
| Forward P/E | 8.2 | 16.8 |
| PEG Ratio | 2.83 | 0.60 |
| EPS | $1.31 | $9.31 |
| Revenue Growth (YoY) | 5.4% | -3.5% |
| Profit Margin | 11.8% | 22.3% |
| Return on Equity | 8.3% | 36.1% |
| Dividend Yield | 7.09% | 1.86% |
| Beta | 0.31 | 1.64 |
| 52-Week High | $28.28 | $258.96 |
| 52-Week Low | $21.97 | $121.54 |
| Volume | -- | -- |
Qualcomm Inc is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Qualcomm Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.